Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Sanctuary_Bio Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::849093025884237825.png) WC [@Sanctuary_Bio](/creator/twitter/Sanctuary_Bio) on x 8948 followers
Created: 2024-10-10 00:48:21 UTC

Let's start with the excellent

$AVXS Zolgensma was a huge success for patients, investors and NVS

$SRPT Elevidys despite the commentary will likely still be a very successful gene therapy commercially


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1844178118309036154/c:line.svg)

**Related Topics**
[$srpt](/topic/$srpt)
[$avxs](/topic/$avxs)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Sanctuary_Bio/status/1844178118309036154)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Sanctuary_Bio Avatar WC @Sanctuary_Bio on x 8948 followers Created: 2024-10-10 00:48:21 UTC

Let's start with the excellent

$AVXS Zolgensma was a huge success for patients, investors and NVS

$SRPT Elevidys despite the commentary will likely still be a very successful gene therapy commercially

XXXXX engagements

Engagements Line Chart

Related Topics $srpt $avxs sarepta therapeutics inc stocks healthcare

Post Link

post/tweet::1844178118309036154
/post/tweet::1844178118309036154